Journal profile · CELL & TISSUE ENGINEERING-CELL BIOLOGY
Stem Cell Reports
ISSN 2213-6711 · Cell Press · UNITED STATES
Stem Cell Reports: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 5.53; fully open access; APC about USD 4,400; median 213 days to acceptance (102 articles, last 24 months); 189 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Stem Cell Reports is published by Cell Press and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Pluripotent Stem Cells Research, CRISPR and Genetic Engineering and Neurogenesis and neuroplasticity mechanisms, together about 41% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Official journal of the International Society for Stem Cell Research (ISSCR) Stem Cell Reports is an open access forum communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on shorter, single-point manuscripts that report original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians.Given the rapidly increasing impact of stem cell research to regenerative medicine and tissue engineering, Stem Cell Reports encourages the submission of manuscripts whose scope bridges these fields of research. The journal also encourages the submission of reports of robust new methodologies with biological significance and/or the potential to advance the application of basic research from the laboratory to the clinic. Stem Cell Reports promotes transparency in stem cell research and related fields of research through the publication of confirmatory findings, negative results, and adverse events.Stem Cell Reports covers: Pluripotency and stem cellsTissue-specific stem cells and their derivativesCellular reprogramming and lineage conversionRegenerative biology across speciesStem cell-derived and adult tissue organoidsCell differentiation, tissue formation, and organogenesisGerm cells and gametogenesisDevelopmental biology of stem cells Cellular hierarchies in cancer Stem cells in homeostasis and agingHuman embryo development and stem cell-based embryo modelsLarge-scale dataset resources for stem cells and developmental biologyDisease modeling with stem cells and organoidsStem cell-informed therapeuticsCell and gene therapyPreclinical and clinical studies in regenerative medicineTissue engineering and biomaterialsStem cell products, manufacturing, and quality controlEthical, policy, standards, and social issues
From the journal's Aims & Scope
Research area (LetPub): CELL & TISSUE ENGINEERING-CELL BIOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology23.2%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology11.2%
- Neurogenesis and neuroplasticity mechanismsNeuroscience6.6%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology5.3%
- Renal and related cancersBiochemistry, Genetics and Molecular Biology4.8%
- 3D Printing in Biomedical ResearchEngineering4%
- Tissue Engineering and Regenerative MedicineMedicine3.7%
- Mesenchymal stem cell researchMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cell & Tissue Engineering | Zone 2 |
| Minor | Cell Biology | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell & Tissue Engineering | Zone 2 |
| Minor | Cell Biology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell & Tissue Engineering | Zone 2 |
| Minor | Cell Biology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.53LetPub ·
- Impact factor (publisher)
- 5.6Publisher website ·
- CiteScore 2026-06
- 9.3LetPub ·
- CiteScore (publisher)
- 9.3Publisher website ·
- SJR 2026-06
- 2.04LetPub ·
- SNIP 2026-06
- 1.17LetPub ·
- h-index
- 55LetPub ·
- h-index
- 150OpenAlex ·
- i10-index
- 2,092OpenAlex ·
- 2-year mean citedness
- 4.96OpenAlex ·
- Self-citation rate
- 1.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 158LetPub ·
Articles by year OpenAlex count · 2,752 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 176 | 176 | 95 |
| 2025 | 189 | 189 | 818 |
| 2024 | 130 | 130 | 1,542 |
| 2023 | 181 | 181 | 3,285 |
| 2022 | 213 | 213 | 5,108 |
| 2021 | 247 | 247 | 9,912 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
213 daysMedian, submission to acceptance · P25–P75 154 days – 285 days
- Acceptance to online
- median 29 days (100 articles)
- Submission to online
- median 243 days
- Sample
- 102 articles with submission and acceptance dates (411 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 28 weeksLetPub ·
- Submission to acceptance
- 178 daysPublisher website ·
- Submission to publication (journal-reported)
- about 34 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 4,400 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 4,190 / EUR 3,880 / GBP 3,350 / JPY 519,690 | — | — | |
| LetPub | USD 3,800 | Yes | — | |
| Publisher website | USD 4,400 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 4,400 (excluding taxes).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Cell Press
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2213-6711
- Society / sponsor
- International Society for Stem Cell Research
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Stem Cell Reports
What CAS zone is Stem Cell Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Stem Cell Reports is in Zone 1 of Medicine, and in Zone 2 of the minor category Cell & Tissue Engineering / Cell Biology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Stem Cell Reports?
The latest impact factor listed by LetPub is 5.53; CiteScore 9.3, h-index 150.
How long does peer review take at Stem Cell Reports?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 213 days (interquartile range 154–285 days); authors report an average review time of about 28 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Stem Cell Reports?
According to LetPub and DOAJ records, Stem Cell Reports is indexed in SCIE, Scopus and DOAJ.
Is Stem Cell Reports open access, and what is the APC?
Stem Cell Reports is a fully open-access journal. APC about USD 4,400.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .